The trademark application HEPLISAV B was filed by Dynavax Technologies Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 14, 2023, and it was registered by office on September 21, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).